- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
PEVE
JKT
Week ended 07 Aug 2026
Weekly Investor Report
PT. Penta Valent Tbk · Healthcare · Pharmaceutical Retailers
Latest close
340.0 IDR
1.2%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -20.4% below the Trend Line and sits at 11.9% of its 52-week range. The latest completed week returned 1.2%, after a 11.1% four-week move. The latest news-sentiment score is 50/100.
Setup score
44
out of 100
Latest Close
340.0 IDR
7 Aug 2026
1W Return
1.2%
latest completed week
4W Return
11.1%
short-term follow-through
12W Return
-3.4%
quarterly tape
Trend Breadth
57.7%
30 of 52 weeks active
Volume Ratio
3.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.2%
Latest completed week; four-week move 11.1%.
Indicator stack
32/61
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -20.4% below the Trend Line and sits at 11.9% of its 52-week range. The latest completed week returned 1.2%, after a 11.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 3.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0312-week average 0.04
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 11.1% over four weeks, -3.4% over 12 weeks, and -23.8% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year30
Trend breadth57.7%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.13Latest activity-pressure read.
Pressure change112.0%Four-week change in activity pressure.
Leadership-11.62Latest relative-leadership reading.
RS change16.4%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 3 relevant articles.
0 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-54.1%Distance below the 52-week high.
13-week volatility4.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher9 of 2617 weeks finished lower.
Best week+6.3%Week of 31 Jul.
Worst week-10.2%Week of 5 Jun.
Latest week+1.2%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains6
Flat weeks0
Modest losses10
Sharp losses7
Recent vol4.5%13-week weekly-return volatility.
Base vol4.7%52-week weekly-return volatility.
Up/down split23/26Count of positive and negative weeks in the 52-week window.
Average skew3.6% / -4.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorID Healthcare
4-week rank4 / 38
Group average4.5%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD44.7%positive activity pressure
RS73.7%positive relative leadership
Four-week leaders
IndustryID Pharmaceutical Retailers
4-week rank1 / 3
Group average6.1%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD66.7%positive activity pressure
RS66.7%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape39/100
Trend, activity pressure, participation, and risk combine to a 39/100 tape read.
Indicator analysis11/100Latest 12-week confirmation: trend 0/12, activity pressure 1/12, relative leadership 0/12.
Activity pressure 0.03; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 3 relevant articles.
PT. Penta Valent Tbk (PEVE.JK) stock price, news, quote and history Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 340.0 IDR | 1.2% | 426.9 IDR | 311.0 IDR | 0.13 | -11.62 | 9.8M | Off |
| 31 Jul 2026 | 336.0 IDR | 6.3% | 435.6 IDR | 310.0 IDR | -0.29 | -10.40 | 7.1M | Off |
| 24 Jul 2026 | 316.0 IDR | 0.6% | 444.0 IDR | 309.0 IDR | -0.69 | -15.08 | 4.5M | Off |
| 17 Jul 2026 | 314.0 IDR | 2.6% | 451.3 IDR | 308.1 IDR | -0.94 | -15.32 | 2.1M | Off |
| 10 Jul 2026 | 306.0 IDR | -0.6% | 459.0 IDR | 307.2 IDR | -1.05 | -13.89 | 1.8M | Off |
| 3 Jul 2026 | 308.0 IDR | -2.5% | 466.5 IDR | 306.3 IDR | -1.17 | -12.52 | 763.6K | Off |
| 26 Jun 2026 | 316.0 IDR | -3.7% | 473.6 IDR | 305.4 IDR | -1.28 | -10.40 | 67.6K | Off |
| 19 Jun 2026 | 328.0 IDR | 5.1% | 479.9 IDR | 304.5 IDR | -1.37 | -11.05 | 36.9K | Off |
| 12 Jun 2026 | 312.0 IDR | 4.0% | 485.6 IDR | 303.4 IDR | -1.45 | -12.84 | 13.7K | Off |
| 5 Jun 2026 | 300.0 IDR | -10.2% | 491.7 IDR | 302.5 IDR | -1.39 | -9.87 | 38.1K | Off |
| 29 May 2026 | 334.0 IDR | 0.6% | 498.6 IDR | 301.7 IDR | -1.30 | -8.17 | 96.3K | Off |
| 22 May 2026 | 332.0 IDR | -5.7% | 504.1 IDR | 300.6 IDR | -1.28 | -9.05 | 547.9K | Off |
| 15 May 2026 | 352.0 IDR | -4.9% | 511.0 IDR | 299.6 IDR | -1.29 | -11.49 | 6.3M | Off |
| 8 May 2026 | 370.0 IDR | -7.5% | 515.2 IDR | 298.4 IDR | -1.34 | -10.15 | 2.8M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.